Package 69097-825-02

Brand: raloxifene hydrochloride

Generic: raloxifene
NDC Package

Package Facts

Identity

Package NDC 69097-825-02
Digits Only 6909782502
Product NDC 69097-825
Description

30 TABLET in 1 BOTTLE (69097-825-02)

Marketing

Marketing Status
Marketed Since 2016-06-29
Brand raloxifene hydrochloride
Generic raloxifene
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ebab2c47-9350-447a-9372-7ade623d5bb1", "openfda": {"unii": ["4F86W47BR6"], "rxcui": ["1490065"], "spl_set_id": ["8fef5bfd-a786-4442-b09b-f3b81812cdac"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-825-02)", "package_ndc": "69097-825-02", "marketing_start_date": "20160629"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-825-07)", "package_ndc": "69097-825-07", "marketing_start_date": "20160629"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-825-15)", "package_ndc": "69097-825-15", "marketing_start_date": "20160629"}], "brand_name": "Raloxifene Hydrochloride", "product_id": "69097-825_ebab2c47-9350-447a-9372-7ade623d5bb1", "dosage_form": "TABLET", "pharm_class": ["Estrogen Agonist/Antagonist [EPC]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "69097-825", "generic_name": "Raloxifene", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Raloxifene Hydrochloride", "active_ingredients": [{"name": "RALOXIFENE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA090842", "marketing_category": "ANDA", "marketing_start_date": "20160629", "listing_expiration_date": "20261231"}